Linda L. Carpenter, MD is a Professor of Psychiatry in the Alpert Medical School of Brown University and Chief of the Mood Disorders Program at Butler Hospital. Dr. Carpenter completed her undergraduate degree in Honors Psychology at the University of Michigan, and subsequently worked as a research assistant in the Mood Disorders Research Program at the Western Psychiatric Institute in Pittsburgh, concurrently completing post-baccalaureate premedical coursework at the University of Pittsburgh. She obtained her MD from the University of Pennsylvania in 1992 and went on to complete an internship in internal medicine, a residency program in psychiatry, and a clinical neuroscience research fellowship at Yale University in 1997. She joined the faculty at Brown in 1997. She has been recognized for her work investigating the neurobiology of, and new treatments for, major depression and other mood and anxiety disorders. She led a 10-year, federally funded translational research program focusing on the development of laboratory biomarkers signaling risk for mood/anxiety disorders, and understanding the impact of early life stress on adult biology. She has conducted a number of randomized clinical trials sponsored by industry and NIH, investigating novel drugs and devices for treating depression. Dr. Carpenter has also been principal investigator on trials examining the efficacy and safety of novel neuromodulation treatments, including Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS) for patients with major depression and/or anxiety disorders. She is Director of the TMS Clinic and Butler Neuromodulation Research Facility, and works with a variety of Brown-based faculty who incorporate noninvasive brain stimulation techniques into their clinical research. Dr. Carpenter is Deputy Director of the COBRE Center for Neuromodulation at Butler Hospital and leads the Center's Neuromodulation and Neuroimaging Core. As mentor to a number of junior research faculty, her lab conducts clinical trials using second-generation noninvasive brain stimulation devices and evaluates potential therapeutic mechanisms of action with EEG and fMRI methods.